Recently, serum levels of IL-18BP were shown as one of the potential biomarkers to discriminate between latent and active TB, further between active TB and non-mycobacterial community-acquired pneumonia (CAP) [73,75,76]. This evidence concerns the gene IL18BP and tuberculosis.